On-Demand Webinars

  1. EU Med Device Regulations: Ensuring Compliance For Integral Combination Products

    Review the EU Medical Device Regulation (MDR) changes, specifically with respect to integral combination products, and examine the technical documentation packages supporting functionality and content.

  2. Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology 5/1/2024

    Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.

  3. Innovations In Pregastric Absorption Drug Delivery And ODTs 3/10/2025

    Experts explore permeation enhancers for drug absorption, PBPK modeling for formulation design, and fast-dissolving orally disintegrating tablets (ODTs) shaping drug development.

  4. From Powder To Particles With Jet Milling

    Gain valuable insights into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development.

  5. Solid Form Screening Of Active Pharmaceutical Ingredients

    Explore the role of solid form services in helping meet accelerated timelines of the drug development lifecycle along with examples of robust workflows for fast and thorough solid form screens.

  6. PBPK Modeling: Mitigating Absorption Risks In Early Drug Development

    Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.

  7. Advanced Analytical Tools For Drug Product Development

    Gain insights on the applications of analytical techniques including Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS).

  8. FDA Guidance: Inspection Of Injectable Products For Visible Particulate

    A review of the draft guidance and importance of component selection as it relates to establishing a risk-based approach and the role of the NovaPure product line in component selection.

  9. Particle Size Control Through Micronization: Challenges And Solutions

    What technical issues need to be addressed if an API is to be successfully micronized? Explore a robust process development strategy that ensures all attributes critical for quality are maintained.

  10. Dry Powder Inhalable Vaccines For Shelf Stability And Global Access 6/3/2024

    What if a formulation that removed the need for cold chain distribution was possible? Explore the formulation of vaccines and manufacturing considerations for dry powder inhaled vaccines.